Oral delivery and fate of poly(lactic acid) microsphere-encapsulated interferon in rats

被引:14
作者
Eyles, JE
Alpar, HO
Conway, BR
Keswick, M
机构
[1] ASTON UNIV,INST PHARMACEUT SCI,BIRMINGHAM B4 7ET,W MIDLANDS,ENGLAND
[2] GLAXO WELLCOME RES & DEV LTD,GREENFORD UB6 0HE,MIDDX,ENGLAND
基金
英国惠康基金;
关键词
D O I
10.1111/j.2042-7158.1997.tb06090.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the light of previous findings which suggest that particulate material can be absorbed and thence systemically disseminated from the gastrointestinal tract, we have investigated the oral uptake and distribution of soluble and microsphere-encapsulated radiolabelled interferon-gamma. For trace-loaded (0.01% w/w interferon) microspheres, a quite different distribution of radioactivity was observed in-vivo 15 and 240 min after oral administration, in comparison with the control group which received equivalent doses of unencapsulated interferon-gamma. Thyroid gland activity in control animals killed at these times was significantly higher than that detected in those rodents receiving trace amounts of microencapsulated interferon-gamma (P less than or equal to 0.05). For poly(L-lactide) particles with higher interferon loadings (0.97% w/w interferon-gamma) the distinction between the two experimental groups was less significant. During incubation in-vitro, the trace-loaded particles released a significantly lower percentage of interferon-gamma in comparison with 0.97% w/w loaded microspheres (P less than or equal to 1). Bio-distribution data from rats treated orally with trace amounts of unencapsulated and microencapsulated interferon-gamma leads us to the tentative conclusion that microencapsulation of proteins markedly affects oral uptake, and possibly post-absorption pharmacokinetic parameters also.
引用
收藏
页码:669 / 674
页数:6
相关论文
共 20 条
[1]   THE TRANSPORT OF MICROSPHERES FROM THE GASTROINTESTINAL-TRACT TO INFLAMMATORY AIR POUCHES IN THE RAT [J].
ALPAR, HO ;
FIELD, WN ;
LEWIS, DA .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1989, 41 (03) :194-196
[2]  
Alpar HO, 1994, P INT S CONTR REL BI, V21, P867
[3]   ENTERIC ABSORPTION OF HUMAN INTERFERON-ALPHA AND INTERFERON-BETA IN THE RAT [J].
BOCCI, V ;
CORRADESCHI, F ;
NALDINI, A ;
LENCIONI, E .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 34 (1-2) :111-114
[4]  
BOCCI V, 1992, CRIT REV THER DRUG, V9, P91
[5]  
CONWAY BR, 1994, P INT S CONTR REL BI, V21, P284
[6]   BIOLOGICAL-ACTIVITY OF LIPOSOME-ENCAPSULATED MURINE INTERFERON-GAMMA IS MEDIATED BY A CELL-MEMBRANE RECEPTOR [J].
EPPSTEIN, DA ;
MARSH, YV ;
VANDERPAS, M ;
FELGNER, PL ;
SCHREIBER, AB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (11) :3688-3692
[7]  
EPPSTEIN DA, 1986, DELIVERY SYSTEMS PEP, P277
[8]   THE MOLECULAR CELL BIOLOGY OF INTERFERON-GAMMA AND ITS RECEPTOR [J].
FARRAR, MA ;
SCHREIBER, RD .
ANNUAL REVIEW OF IMMUNOLOGY, 1993, 11 :571-611
[9]  
FLORENCE AT, 1993, PHARM PARTICULATE CA, V61, P65
[10]  
GRIFFIN KF, 1997, UNPUB VACCINE